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Abstract
Background: To determine the prevalence of carriage of respiratory bacterial pathogens, and the risk factors for
and serotype distribution of pneumococcal carriage in an Australian Aboriginal population.
Methods: Surveys of nasopharyngeal carriage of Streptococcus pneumoniae, non-typeable Haemophilus influenzae,
and Moraxella catarrhalis were conducted among adults (≥16 years) and children (2 to 15 years) in four rural
communities in 2002 and 2004. Infant seven-valent pneumococcal conjugate vaccine (7PCV) with booster 23-valent
pneumococcal polysaccharide vaccine was introduced in 2001. Standard microbiological methods were used.
Results: At the time of the 2002 survey, 94% of eligible children had received catch-up pneumococcal vaccination.
324 adults (538 examinations) and 218 children (350 examinations) were enrolled. Pneumococcal carriage
prevalence was 26% (95% CI, 22-30) among adults and 67% (95% CI, 62-72) among children. Carriage of non-
typeable H. influenzae among adults and children was 23% (95% CI, 19-27) and 57% (95% CI, 52-63) respectively
and for M. catarrhalis, 17% (95% CI, 14-21) and 74% (95% CI, 69-78) respectively. Adult pneumococcal carriage was
associated with increasing age (p = 0.0005 test of trend), concurrent carriage of non-typeable H. influenzae (Odds
ratio [OR] 6.74; 95% CI, 4.06-11.2) or M. catarrhalis (OR 3.27; 95% CI, 1.97-5.45), male sex (OR 2.21; 95% CI, 1.31-3.73),
rhinorrhoea (OR 1.66; 95% CI, 1.05-2.64), and frequent exposure to outside fires (OR 6.89; 95% CI, 1.87-25.4). Among
children, pneumococcal carriage was associated with decreasing age (p < 0.0001 test of trend), and carriage of
non-typeable H. influenzae (OR 9.34; 95% CI, 4.71-18.5) or M. catarrhalis (OR 2.67; 95% CI, 1.34-5.33). Excluding an
outbreak of serotype 1 in children, the percentages of serotypes included in 7, 10, and 13PCV were 23%, 23%, and
29% (adults) and 22%, 24%, and 40% (2-15 years). Dominance of serotype 16F, and persistent 19F and 6B carriage
three years after initiation of 7PCV is noteworthy.
Conclusions: Population-based carriage of S. pneumoniae, non-typeable H. influenzae, and M. catarrhalis was high
in this Australian Aboriginal population. Reducing smoke exposure may reduce pneumococcal carriage. The
indirect effects of 10 or 13PCV, above those of 7PCV, among adults in this population may be limited.
Background
Streptococcus pneumoniae is responsible for an estimated
14.5 million episodes of serious disease and 826,000 deaths
annually among children aged 1 to 59 months [1]. The
burden of pneumococcal disease in older age groups is
unknown. Streptococcus pneumoniae is the most common
cause of pneumonia [2,3] while both non-typeable Haemo-
philus influenzae (indicated subsequently as H. influenzae)
and Moraxella catarrhalis are associated with exacerba-
tions of chronic obstructive airways disease [4,5]. Among
Australia’s Northern Territory (NT) Aboriginal popula-
tion, respiratory causes are responsible for 18% of deaths
[6]. Aboriginal adults and older children also experience
high rates of invasive pneumococcal disease (IPD) [7].
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sodes of pneumococcal carriage acquisition [8,9]. Pneu-
mococcal conjugate vaccines (PCV) reduce carriage of
vaccine serotypes (VT) with increased carriage of non-
vaccine serotypes [10,11]. The importance of the impact
of PCV on carriage has been highlighted by the large
indirect effects observed following introduction of
7-valent PCV (7PCV) in the United States [12]. How-
ever, the characteristics of population-level pneumococ-
cal carriage epidemiology which influence the indirect
effects of PCV are not well described. Whether such
indirect effects can be expected in populations with dif-
ferent pneumococcal carriage epidemiology is unknown.
Data concerning nasopharyngeal carriage of S. pneu-
moniae, H. influenzae,a n dM. catarrhalis in high-risk
populations, such as Aboriginal adults and older chil-
dren, are limited. The NT of Australia introduced 7PCV
and 23-valent pneumococcal polysaccharide vaccine
(23PPV) for Aboriginal children in late 2001. Despite
high levels of vaccination coverage, a study describing
the indirect effects of universal pneumococcal vaccina-
tion in the four Aboriginal communities involved in this
study documented the same VT carriage prevalence in
2002 and 2004 [13]. Further aims of this study were to
determine the age-specific prevalence of respiratory bac-
terial carriage in children and adults, as well as the risk
factors for and serotype distribution of pneumococcal
carriage among those aged 2 years and over.
Methods
Study population
We performed two surveys in the four main communities
(> 90% of the total population) on the Tiwi Islands, 70
km north of Darwin, off the coast of the NT. In 2002, the
population was 2,204 and 92% of individuals identified as
Aboriginal. NT immunization policy recommended
23PPV for Aboriginal adults > 15 years of age. A 7PCV
catch-up campaign for those < 2 years of age began in
August 2001 along with three doses of 7PCV at 2, 4, and
6 months of age and booster 23PPV at 18 months of age.
Procedures
Participants were enrolled in 2002 (August - November)
and these individuals were followed up, along with
others in 2004 (March - May). The 2002 and 2004 sur-
veys were conducted during dry and wet seasons respec-
tively. Eligibility criteria were: permanent residence,
Aboriginal ethnicity, and age ≥2 years. Purposive sam-
pling aimed to obtain equal numbers of ‘typical’ males
and females in each of two groups; adults (≥16 years of
age) and children (≥2 and < 16 years of age). To obtain
more precise estimates of prevalence among adults with
lower carriage than children, sampling aimed to enrol
1.5 times the number of adults than children. We visited
a range of work places, public locations, schools and pri-
vate residences.
Written informed consent was obtained after partici-
pants read the study information or had it explained to
them in English or Tiwi. When consent was discussed
with adults, consent was also sought for enrolment of
their children. The study was conducted in accordance
with the Declaration of Helsinki and was approved by
the Tiwi Health Board and the NT Department of
Health and Community Services, Human Research
Ethics Committee.
Demographic and risk factor data, as well as informa-
tion from community clinic records, were recorded on
standard forms. Dates of pneumococcal and influenza
vaccination were extracted from clinic records, the com-
munity clinic and NT immunisation databases.
Microbiological methods
Nasopharyngeal swabs and culture used methods similar
to those proposed by WHO [14]. Methodological varia-
tions were: swab placement for 10 rather than 5 seconds
and rotation 360° rather than 180°. Aluminium-shafted,
cotton-tipped swabs (Disposable Products, Australia)
were introduced horizontally into the nasal cavity 8-10
cm or until resistance was encountered. If the first swab
was not tolerated a second swab was performed or nasal
secretions were collected from a tissue used to blow the
nose [15]. Swabs were placed immediately into skimmed
milk glucose glycerol broth and stored at -20°C for trans-
port to the laboratory for storage at -70°C. A 10 μLl o o p
of broth was streaked on bacitracin containing horse
blood agar and chocolate agar (Oxoid, Australia). Plates
were incubated overnight at 37°C in 5% CO2. Isolation of
S. pneumoniae was confirmed by colony morphology,
optochin sensitivity and serotyping by the Quellung reac-
tion (Statens Serum Institut, Denmark), H. influenzae by
dependence on X and V factors, and M. catarrhalis by
colony morphology, Gram stain and oxidase production.
Statistical analysis
Data from 2002 and 2004 were aggregated for analysis
of risk factors based on the following criteria: a) carriage
prevalence in 2002 and 2004 not significantly different,
b) concordant direction of association in univariate ana-
lyses, and c) univariate associations showing p ≤ 0.20.
Multiple logistic regression was used for risk factor ana-
lysis. Adjustment for correlation between individual
pairs of observations in the two surveys was made by
including participant identity as a clustering variable in
logistic models. Effect modification between variables
was evaluated.
Given carriage of 40% in Aboriginal mothers in these
communities, the primary risk factor for analysis was
sex. A 30% prevalence in men was assumed to be
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size of 376 males and 376 females was required to
detect the difference at the 5% significance level with
power of 0.8.
Results
At the time of the 2002 survey, 94% of eligible children
had received pneumococcal catch-up vaccination and
the mean age at the third dose was 6.7 months (range
4.2 - 13.6). In 2004, all eligible children had received
three doses of 7PCV with 33% receiving the third dose
greater than 7 months of age. The proportion of partici-
pants < 5 years of age, who had received 7PCV in 2002
and 2004, was 30% and 73% respectively. In 2002, 87%
of participants ≥15 years had received 23PPV.
A total of 943 specimens were collected from 925
examinations of 551 participants. After exclusions, 905
specimens from 888 examinations of 538 participants
remained for analysis (Figure 1). Of all examinations,
60.6% were in adults (> 16 years) and 44.4% were in
males. Males comprised a smaller proportion of exami-
nations among adults (Figure 1).
The prevalence of pneumococcal carriage in all exami-
nations was 42.3% (376/888). Carriage prevalence among
adults was 28.4% in 2002 and 22.8% in 2004, odds ratio
(OR) 0.75 (95% CI, 0.54-1.02). Carriage among children
in 2002 was 69.6% and 64.8% in 2004 (OR 0.80; 95% CI,
0.54-1.19). H. influenzae carriage in all examinations
was 36.5% (324/888), while carriage prevalence among
adults was 24.8% in 2002 and 20.3% in 2004; carriage
prevalence in children was 61.3% in 2002 and 52.8% in
2004. M. catarrhalis carriage in all examinations was
39.4% (350/888), 15.7% among adults in 2002 and 19.0%
in 2004 with carriage among children of 74.3% in 2002
and 73.0% in 2004 (Table 1).
Pneumococcal carriage was greatest in young children
and older age categories (Figure 2). Among adults there
was a trend of increasing carriage with increasing age
(Table 1). The trend among children was even greater but
inverse, pneumococcal carriage decreased greatly with
increasing age (Table 1). Carriage of H. influenzae and
M. catarrhalis showed no pattern over adult age groups
but carriage fell with increasing age of children (Figure 2).
Among adults, univariate analyses showed pneumococ-
cal carriage was associated with male sex, chest infection
in the previous month, recent runny nose, 1-2 household
occupants < 5 years of age, frequency sitting at an outside
fire, a young child as the closest personal contact and
concurrent carriage of H. influenzae or M. catarrhalis
(Table 2). Among children, carriage was associated with
recent runny nose, the number of household occupants
< 5 years of age, the number of bedroom occupants < 5
years of age, and concurrent carriage of H. influenzae
and M. catarrhalis (Table 2).
Multivariate analysis showed independent risk factors
(10% significance level) for pneumococcal carriage
among adults were: increasing age, male sex, chest infec-
tion in the previous month, runny nose in the previous
week, frequency of sitting at an outside fire and concur-
rent carriage of H. influenzae or M. catarrhalis (Table 3).
Among children, independent risk factors for carriage
were decreasing age, runny nose in the previous week,
and concurrent carriage of H. influenzae or M. catarrha-
lis (Table 3).
There was no effect modification of H. influenzae or
M. catarrhalis carriage, with risk of pneumococcal car-
riage, nor effect modification of pneumococcal carriage
and carriage of H. influenzae or M. catarrhalis.
Thirty-nine pneumococcal serotypes were identified.
Among adults the predominant types were 6B, 7C, 16F,
19F, and 34 (Figure 3A). Among those < 15 years, sero-
types 16F, 1, 11A, 19F, and 6A predominated (Figure 3B),
while among those < 5 years, serotypes 16F, 19A, 6B, 1,
and 11A predominated (Figure 3C). An epidemic of sero-
type 1 carriage was evident in 2002 [16]. Serotype 1 car-
riage was not detected in 2004. Excluding the outbreak of
serotype 1, the percentages of serotypes included in the
7, 10, and 13-valent PCV were 23%, 23%, and 29%
( a d u l t s ) ,2 2 % ,2 4 % ,a n d4 0 %( <1 5y e a r s ) ,a n d2 6 % ,2 6 % ,
and 40% (< 5 years) respectively. Dominance of serotype
16F, and persistent 19F and 6B carriage (particularly
among adults) is noteworthy (Figure 3).
Discussion
This is the first population-based study of respiratory
bacterial carriage prevalence and risk factors among
Australian Aboriginal adults and older children. Pneu-
mococcal carriage prevalence was 67.4% in children age
2-15 years and 26.0% in adults. The prevalence of H.
influenzae carriage was 57.4% in 2-15 year old children
and 22.9% in adults. Of the three pathogens, M. catar-
rhalis was the most prevalent in children (73.7%), and
the least prevalent in adults (17.1%). Pneumococcal car-
riage among adults was associated with increasing age,
male sex, recent chest infection, recent rhinorrhoea, fre-
quency of sitting at an outside fire, and concurrent car-
riage of H. influenzae or M. catarrhalis.A m o n go l d e r
children, pneumococcal carriage was strongly associated
with younger age and concurrent carriage of H. influen-
zae or M.catarrhalis and less strongly associated with
recent rhinorrhoea. A large number of pneumococcal
serotypes circulate in this population. Higher valency
PCVs would cover a greater proportion of serotypes in
children than adults.
Compared to other population-based studies of pneu-
mococcal carriage, the 42% overall prevalence in this
population (mean age 25 years) was midway between
that observed among Gambian villagers (65%, median
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age 16 years) [18] or Kilifi, Kenya (20%, mean age 9
years) [19]. Lower carriage (> 2 years) has been reported
in the UK (16%) [20] and Taiwan (10%) [21].
Pneumococcal carriage among children (67%) in this
population (mean age 8 years) was comparable to 82%
in 5 to 14 year old Gambians [17] and greater than
among 5 to 19 year olds in Kilifi (25%), 5 to 17 year old
Brazilian slum residents (45%), and Brazilian adolescents
(10%) [22]. Pneumococcal carriage among adults in this
population (26%) was lower than in Gambia (50%), simi-
lar to a Brazilian slum (20%), and greater than in Kilifi
Figure 1 Enrolment and follow-up profile. Note: Number of eligible adults (324) and children (218) is not equal to the total number of
eligible participants (538) as four participants were categorized as children in 2002 and then categorized as adults in 2004.
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from Central Australia reported pneumococcal carriage
in 34% of a selected group of Aboriginal adults [23].
The differences in prevalence noted above are difficult
to explain due to a lack of data on methodology and
comparable risk factors.
H. influenzae carriage in children (63%) was greater
than that reported in north Indian primary school
children (42%, 5-10 years) [24] or Kilifi (22%, 3-9 years)
[19]. Carriage of M. catarrhalis (74% children, 17%
adults) was greater than that reported in previous
studies of healthy children (51%) and adults (5%) in
Belgium [25] and hospitalized children (7%, 4-15 years)
and adults (1%) in Denmark [26].
The decreasing pneumococcal carriage with increasing
age of children has been described in other studies,










*Odds ratio S. pneumoniae carriage
(95% CI)
Adults
16-24 26/133 (19.6) 14/133 (10.5) 23/133 (17.3) 1
25-34 35/135 (25.9) 29/135 (21.5) 30/135 (22.2) 1.37 (0.68-2.74)
35-44 23/120 (19.2) 21/120 (17.5) 37/120 (30.8) 2.13 (1.09-4.15)
45-54 22/95 (23) 15/95 (16) 29/95 (31) 2.10 (1.04-4.26)
≥55 17/55 (31) 13/55 (24) 21/55 (38) 2.95 (1.30-6.69)
Total 123/538 (22.9) 92/538 (17.1) 140/538 (26.0)
Children
2-4 70/102 (68.6) 91/102 (89.2) 84/102 (82.4) 1
5-8 84/132 (63.6) 104/132 (78.8) 96/132 (72.7) 0.57 (0.29-1.11)
9-12 37/93 (40) 53/93 (57) 48/93 (52) 0.23 (0.12-0.45)
13-15 10/23 (44) 10/23 (43) 7/23 (30) 0.09 (0.03-0.27)
Total 201/350 (57.4) 258/350 (73.7) 235/350 (67.1)
Figure 2 Carriage of H. influenzae, M. catarrhalis, and S. pneumoniae by age group (in years) in the two surveys combined.
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[17-21]. Of note, the studies cited here have been con-
ducted in populations before introduction of 7PCV. Car-
r i a g ep r e v a l e n c eo fH. influenzae and M. catarrhalis
among children also fell with increasing age.
Interestingly, the increased pneumococcal carriage with
increasing adult age (38% ≥55 years versus 20% among 16
to 34 year olds) that we observed was not seen in The
Gambia or Kilifi. The reason for increased carriage in
older adults is not clear. It is unlikely that the trend of
increasing pneumococcal carriage is due to chance (test
for trend 2002, p = 0.05; 2004, p = 0.003; overall, p =
0.0005). Patterns of social interaction, particularly expo-
sure to children, are usually less intense in older adults but
Table 2 Adults and children, univariate associations between explanatory variables and pneumococcal carriage
(aggregate data for 2002 and 2004)
Variable Adults Children
Positive carriage (%) Odds ratio p-value Positive carriage (%) Odds ratio p-value
Sex Female 72/324 (22) 1 n/a n/a
Male 68/214 (32) 1.63 (1.04-2.56) 0.03
Chest infection in the
previous month
No 67/329 (20) 1 n/a n/a
Yes 70/200 (35) 2.11 (1.40-3.18) < 0.01
Runny nose in the
previous week
No 60/306 (20) 1 76/142 (54) 1
Yes 71/214 (33) 2.04 (1.37-3.02) < 0.01 147/187 (79) 3.19 (1.97-5.17) < 0.01
Number household
occupants
0 92/306 (30) 1 59/103 (57) 1
1-2 37/187 (20) 0.57 (0.37-0.89) 0.01 136/191 (71) 1.84 (1.10-3.08) 0.02
< 5 years ≥3 10/39 (26) 0.80 (0.36-1.77) 0.58 38/49 (78) 2.58 (1.14-5.83) 0.02
Number bedroom
occupants
0 n/a n/a 142/224 (63) 1
1 27/40 (68) 1.35 (0.63-2.90) 0.44
< 5 years ≥2 67/86 (78) 2.12 (1.18-3.81) 0.01
Sits at an outside fire n/a n/a
Never/monthly 35/172 (20) 1
Most days 96/347 (28) 1.50 (0.99-2.26) 0.05
Every day 7/11 (64) 6.9 (1.9-24.5) < 0.01
Daytime location n/a n/a School 167/263 (64) 1
Creche 14/14 (100) n/a
Home 22/31 (71) 1.41 (0.64-3.07) 0.39
With carer 32/36 (89) 4.60 (1.60-13.2) < 0.01
Closest personal contact
Adult 118/403 (29) 1 School 170/268 (63) 1
School child 4/25 (16) 0.46 (0.15-1.41) 0.18 Creche 20/22 (91) 5.76 (1.29-25.8) 0.02
Creche child 3/14 (21) 0.66 (0.17-2.50) 0.54 Mother 43/50 (86) 3.54 (1.55-8.1) < 0.01
Young child 14/88 (16) 0.46 (0.23-0.90) 0.02
H. influenzae detected No 68/415 (16) 1 57/149 (38) 1
Yes 72/123 (59) 7.20 (4.59-11.3) < 0.01 178/201 (89) 12.49 (6.96-22.4) < 0.01
M. catarrhalis detected No 94/446 (21) 1 35/92 (38) 1
Yes 46/92 (52) 3.74 (2.36-5.95) < 0.01 200/258 (78) 5.62 (3.21-9.81) < 0.01
Note: Odds ratios and confidence intervals calculated by logistic regression and adjusted for repeated measures. n/a, not applicable. Adult risk factors excluded
from aggregation of 2002 and 2004 data: antibiotic prescription in the previous month, number of bedroom occupants, diagnosis of rheumatic heart disease or
chronic lung disease (data not shown), current smoker, fire outside the house, 23PPV in the previous 2 years, number of bedroom occupants < 5 years of age,
bedroom occupant includes a child, employed, record of proteinuria or diabetes, influenza vaccination in the previous 2 years, record of excessive alcohol use.
Risk factors included in aggregate data: sex, chest infection in the previous month, runny nose in the previous week, number of household occupants < 5 years
of age, closest personal contact (young child versus adult), and concurrent carriage of H. influenzae or M. catarrhalis. Frequency sitting at an outside fire was
included in aggregate data as p = 0.003 for one category in 2002 but no observations in that category in 2004. Among children, risk factors excluded from
aggregation: antibiotic prescription in the previous month, fire outside the house, number of household occupants, number of bedroom occupants, and
bedroom occupant includes an adult. Risk factors included in aggregate data: runny nose in the previous week, number of household occupants < 5 years of
age, number of bedroom occupants < 5 years of age, daytime location, closest personal contact (mother versus school children), and concurrent carriage of
H. influenzae or M. catarrhalis.
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nescence), environmental (e.g. smoke exposure, stress),
and chronic disease factors may also be important.
Odds of pneumococcal carriage were substantially
increased if H. influenzae or M. catarrhalis were also
detected. The Kilifi study reported a similar magnitude
of association between pneumococcal carriage and con-
current carriage of H. influenzae [19]. The association
with detection of other pathogens may reflect either
facilitation of pneumococcal carriage by H. influenzae or
M. catarrhalis, or simply non-species specific risk of
nasopharyngeal carriage.
Our data, as well as contemporary [19,27] and histori-
cal [28] studies, describe increased pneumococcal car-
riage associated with upper respiratory infections. Our
data also indicate an association of recent chest infec-
tion with increased pneumococcal carriage in adults.
Episodes of pneumonia are associated with increased
pneumococcal carriage [29,30].
We found 2.2 times the odds of pneumococcal car-
riage among adult males compared to females. An asso-
ciation of carriage with gender has not been reported in
most studies [17,19,27,28], an exception being one study
of adolescents [22]. Some of the factors potentially asso-
ciated with both gender and carriage, such as contact
with children, chronic illness, smoking or sitting at an
outside fire, were included in multivariate analyses.
Pneumococcal carriage and respiratory infection have
been associated with exposure to air pollution of
different types [22,31]. We found the frequency of sit-
ting at an outside fire increased the risk of pneumococ-
cal carriage. Sitting and cooking at outside fires is
common in rural Aboriginal communities. Thus, our
data strengthen the growing body of evidence linking
smoke exposure to increased risk of respiratory
infection.
The large number of pneumococcal carriage serotypes
which were detected suggests that pneumococcal trans-
mission is substantial in this population. Our data sug-
gest that the indirect effects of higher valency PCV may
be greater than 7PCV (particularly for young infants
who acquire S. pneumoniae from their siblings), with a
more limited incremental effect among adults.
Our study has a number of limitations. Our sample col-
lection methods underestimate carriage prevalence. Non-
probability sampling may have introduced selection bias.
Sampling aimed to identify equal numbers of typical
adult men and women, with children numbering two
thirds that of adults. However, sampling was biased
towards adult women, and given lower carriage in
women, adult carriage may be underestimated. Analyses
of risk factors need to be interpreted in the light of possi-
ble sampling bias. Despite non-probability sampling,
valid prevalence estimates are likely to fall within the
given confidence intervals. Finally, this study is limited to
a three year period following the introduction of 7PCV.
Although carriage of serotypes 19F and 6B in 2004
remained substantial, it may have fallen in subsequent
Table 3 Multivariate model of risk factors for pneumococcal carriage among adults and children
Risk factor Adults Children
Category Odds Ratio (95% CI) Category Odds Ratio (95% CI)
Age group 16-24 yrs 1 2-4 yrs 1
25-34 yrs 1.13 (0.52-2.49) 5-8 yrs 0.65 (0.28-1.54)
35-44 yrs 2.04 (0.92-4.54) 9-12 yrs 0.43 (0.17-1.08)
45-54 yrs 1.90 (0.83-4.34) 13-15 yrs 0.13 (0.03-0.56)
≥55 yrs 2.19 (0.88-5.50)
Sex Female 1 n/a
Male 2.21 (1.31-3.73)
Chest infection in previous month No 1 n/a
Yes 1.62 (0.98-2.67)
Runny nose in previous week No 1 No 1
Yes 1.66 (1.05-2.64) Yes 1.80 (0.98-3.29)
Frequency sitting at an outside fire Never/monthly 1 n/a
Most days/weekly 1.23 (0.74-2.05)
Every day 6.89 (1.87-25.4)
H. influenzae detected No 1 No 1
Yes 6.74 (4.06-11.2) Yes 9.34 (4.71-18.5)
M. catarrhalis detected No 1 No 1
Yes 3.27 (1.97-5.45) Yes 2.67 (1.34-5.33)
Note: Odds ratios and confidence intervals calculated by logistic regression adjusting for repeated measures on an individual.
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little change in childhood carriage of 19F and 23F
between 2003 and 2005 but a reduction in carriage of 6B
was observed [32].
The implications for public health relate to the introduc-
tion of PCV and prevention of pneumococcal transmission
and disease. High overall carriage prevalence indicates a
large proportion of the population contributing to
pneumococcal transmission, which is consistent with the
high rates of IPD observed among Aboriginal adults [7].
Such a reservoir of potentially transmitting individuals
may maintain circulation of pneumococcal serotypes after
introduction of PCV and limit the magnitude, and increase
the time to development, of indirect effects. High rates of
bacterial carriage also suggest potential for replacement
disease following reduction of VT carriage. Ongoing
Figure 3 Pneumococcal carriage serotype distributions in the two surveys combined: A) Adults, B) Age < 15 years, and C) Age < 5 years.
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explain data showing no reduction in rates of IPD in
Aboriginal adults following introduction of 7PCV despite
a 30% to 45% reduction in IPD among all Australian adults
following 7PCV introduction [33].
Conclusion
Nasopharyngeal carriage of S. pneumonia, H. influenzae,
and M. catarrhalis is high in this population. These data
indicate that frequent exposure to outside fires and pre-
valent respiratory viral and bacterial infections all play a
role in maintaining high rates of pneumococcal carriage.
Interventions which reduce smoke exposure may reduce
pneumococcal carriage. Among adults, low serotype
coverage of higher valency PCV suggests that increased
herd protection above that of 7PCV may be limited,
although higher coverage among children, particularly
during a serotype 1 outbreak, suggests that increased
herd protection will be afforded to young infants.
Ongoing carriage of 7PCV serotypes 19F and 6B is note-
worthy, although our data are limited to a three year
period following introduction of 7PCV.
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